西药公司(West Pharmaceutical Services Inc,WST)今日盘中股价大跌23.14%,引发市场广泛关注。
公司公布的2025年业绩预期大幅低于市场预期,成为导致股价暴跌的主因。西药公司预计2025年全年收入在28.8亿到29.1亿美元之间,中位值低于分析师平均预期的30.4亿美元;同时,公司全年每股利润预期在6美元到6.2美元区间,也远远不及市场预期的7.44美元。
西药公司解释称,业绩预期不佳主要是受到美元走强以及生物科技客户去库存行为的影响。疫情期间,西药公司的生物技术客户曾因供应链中断而大量囤积库存,但现在需求下降令公司业绩承压。此外,专有产品业务去年第四季度同比增长放缓,也对全年业绩造成一定冲击。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.